Skip to main content
logo
Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.000
+0.080 (2.74%)
At close: Sep 8, 2026

Coegin Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
86110785197228
Market Cap Growth
-37.31%40.73%55.23%-47.61%-57.65%-
Enterprise Value
83103694492197
Last Close Price
3.004.443.855.3813.4636.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
198.091398.18----
PB Ratio
14.1723.293.117.494.5911.35
P/TBV Ratio
19.9070.624.09-10.4611.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
192.361304.89----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.41-1.67-0.78-0.82-0.18-1.28
Net Debt / EBITDA Ratio
0.130.460.970.220.120.94
Net Debt / FCF Ratio
0.110.480.830.250.101.19
Asset Turnover
0.030.00----
Quick Ratio
1.590.9911.610.710.842.95
Current Ratio
2.771.1611.710.720.852.96
Return on Equity (ROE)
-199.51%-136.64%-148.58%-201.53%-171.54%-147.59%
Return on Assets (ROA)
-103.96%-63.31%-68.67%-77.82%-72.78%-68.67%
Return on Capital Employed (ROCE)
-356.90%-431.20%-92.40%-412.00%-165.10%-135.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-25.30%-18.56%-30.30%-55.34%-36.52%-11.91%
FCF Yield
-25.42%-15.09%-30.12%-43.58%-39.61%-9.43%
Buyback Yield / Dilution
-9.46%-31.30%-105.53%-34.42%-15.36%-354.98%